Fig. 6From: Early postnatal microglial ablation in the Ccdc39 mouse model reveals adverse effects on brain development and in neonatal hydrocephalusPLX-treated prh animals do not have survival or growth advantage over untreated-prh animals. A Survival rate of untreated-WT, PLX-treated WT, untreated-prh, and PLX-treated prh up to P20 (n ≥ 5 in each group) shows both untreated and PLX-prh mutants have significantly lower survival rate when compared to WTs (**p < 0.01, *p < 0.05, log-rank test). B Body weight analysis. There is no significant difference in the daily (P3-P20) weight in grams (g) among untreated-WT, PLX- treated WT, untreated-prh, and PLX- treated prh mice up to P20, (repeated measures of two-way ANOVA, followed by Tukey’s test)Back to article page